Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT02461589

Public ClinicalTrials.gov record NCT02461589. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 12:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT02461589
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
706 participants

Conditions and interventions

Interventions

  • liraglutide Drug
  • placebo Drug
  • semaglutide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 20, 2015
Primary completion
Oct 12, 2016
Completion
Oct 12, 2016
Last update posted
Jul 30, 2019

2015 – 2016

United States locations

U.S. sites
84
U.S. states
31
U.S. cities
74
Facility City State ZIP Site status
Novo Nordisk Investigational Site Birmingham Alabama 35209
Novo Nordisk Investigational Site Birmingham Alabama 35294
Novo Nordisk Investigational Site Coronado California 92118
Novo Nordisk Investigational Site Lancaster California 93534
Novo Nordisk Investigational Site Riverside California 92506
Novo Nordisk Investigational Site Tustin California 92780
Novo Nordisk Investigational Site Van Nuys California 91405
Novo Nordisk Investigational Site Vista California 92083
Novo Nordisk Investigational Site Walnut Creek California 94598
Novo Nordisk Investigational Site Hartford Connecticut 06105
Novo Nordisk Investigational Site Boca Raton Florida 33433
Novo Nordisk Investigational Site Gainesville Florida 32609
Novo Nordisk Investigational Site Gainesville Florida 32653
Novo Nordisk Investigational Site Hialeah Florida 33012
Novo Nordisk Investigational Site Miami Florida 33173
Novo Nordisk Investigational Site Miami Florida 33183
Novo Nordisk Investigational Site Pembroke Pines Florida 33026
Novo Nordisk Investigational Site Ponte Vedra Florida 32081
Novo Nordisk Investigational Site Atlanta Georgia 30342
Novo Nordisk Investigational Site Marietta Georgia 30067
Novo Nordisk Investigational Site Evanston Illinois 60201-2477
Novo Nordisk Investigational Site Evansville Indiana 47714
Novo Nordisk Investigational Site Newton Kansas 67114
Novo Nordisk Investigational Site Louisville Kentucky 40206
Novo Nordisk Investigational Site Madisonville Kentucky 42431
Novo Nordisk Investigational Site Marrero Louisiana 70072
Novo Nordisk Investigational Site Slidell Louisiana 70458
Novo Nordisk Investigational Site Slidell Louisiana 70461-4231
Novo Nordisk Investigational Site Rockville Maryland 20852
Novo Nordisk Investigational Site Boston Massachusetts 02215
Novo Nordisk Investigational Site Buckley Michigan 49620
Novo Nordisk Investigational Site Belzoni Mississippi 39038
Novo Nordisk Investigational Site Bridgeton Missouri 63044
Novo Nordisk Investigational Site Kalispell Montana 59901
Novo Nordisk Investigational Site Elkhorn Nebraska 68022
Novo Nordisk Investigational Site Las Vegas Nevada 89103
Novo Nordisk Investigational Site Lawrenceville New Jersey 08648
Novo Nordisk Investigational Site Hopewell Junction New York 12553
Novo Nordisk Investigational Site Statesville North Carolina 28625
Novo Nordisk Investigational Site Cincinnati Ohio 45219
Novo Nordisk Investigational Site Cincinnati Ohio 45227
Novo Nordisk Investigational Site Cincinnati Ohio 45255
Novo Nordisk Investigational Site Delaware Ohio 43015
Novo Nordisk Investigational Site Dublin Ohio 43016
Novo Nordisk Investigational Site Kettering Ohio 45429
Novo Nordisk Investigational Site Mason Ohio 45040-6815
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73112
Novo Nordisk Investigational Site Corvallis Oregon 97330-3737
Novo Nordisk Investigational Site Downingtown Pennsylvania 19335-2620
Novo Nordisk Investigational Site Media Pennsylvania 19063
Novo Nordisk Investigational Site Smithfield Pennsylvania 15478
Novo Nordisk Investigational Site Uniontown Pennsylvania 15401
Novo Nordisk Investigational Site Charleston South Carolina 29412
Novo Nordisk Investigational Site Hodges South Carolina 29653
Novo Nordisk Investigational Site Mt. Pleasant South Carolina 29464
Novo Nordisk Investigational Site Old Point Station South Carolina 29707
Novo Nordisk Investigational Site Bristol Tennessee 37620-7352
Novo Nordisk Investigational Site Chattanooga Tennessee 37404
Novo Nordisk Investigational Site Johnson City Tennessee 37604
Novo Nordisk Investigational Site Kingsport Tennessee 37660
Novo Nordisk Investigational Site Memphis Tennessee 38119-4806
Novo Nordisk Investigational Site Nashville Tennessee 37203
Novo Nordisk Investigational Site Arlington Texas 76012-4637
Novo Nordisk Investigational Site Austin Texas 78705
Novo Nordisk Investigational Site Carrollton Texas 75010
Novo Nordisk Investigational Site Dallas Texas 75220
Novo Nordisk Investigational Site Dallas Texas 75230
Novo Nordisk Investigational Site Dallas Texas 75251
Novo Nordisk Investigational Site Dallas Texas 75390-9302
Novo Nordisk Investigational Site Houston Texas 77008
Novo Nordisk Investigational Site Missouri City Texas 77459
Novo Nordisk Investigational Site New Braunfels Texas 78130
Novo Nordisk Investigational Site San Antonio Texas 78230
Novo Nordisk Investigational Site San Antonio Texas 78258
Novo Nordisk Investigational Site Sugar Land Texas 77479
Novo Nordisk Investigational Site Waco Texas 76710
Novo Nordisk Investigational Site Bountiful Utah 84010
Novo Nordisk Investigational Site Clinton Utah 84015
Novo Nordisk Investigational Site Riverton Utah 84065
Novo Nordisk Investigational Site Richmond Virginia 23219
Novo Nordisk Investigational Site Virginia Beach Virginia 23454
Novo Nordisk Investigational Site Winchester Virginia 22601
Novo Nordisk Investigational Site Renton Washington 98057
Novo Nordisk Investigational Site Spokane Washington 99216-1557

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 66 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02461589, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 30, 2019 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02461589 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →